Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4002605 | 0.81 | LMNA (0.43) | MIFLMNA | |
| SCHEMBL9183404 | 0.77 | MIF (0.32) | MIFLMNA | |
| SCHEMBL7830363 | 0.77 | MIF (0.32) | MIFLMNA | |
| SCHEMBL9183340 | 0.77 | MIF (0.32) | MIFLMNA | |
| SCHEMBL6893982 | 0.77 | MMP1 (0.32) | MIFLMNA | |
| SCHEMBL6898384 | 0.77 | MMP1 (0.32) | MIFLMNA | |
| SCHEMBL6895213 | 0.77 | CYP3A4 (0.33) | MIFLMNA | |
| SCHEMBL9945575 | 0.76 | MIF (0.31) | MIFLMNA | |
| SCHEMBL28714347 | 0.76 | EPHX2 (0.33) | MIFLMNA | |
| SCHEMBL2986793 | 0.76 | EPHX2 (0.33) | MIFLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8324273-B2 | Catechol protected levodopa diester prodrugs, compositions, and methods of use | XENOPORT, INC. (US) | 2012-12-04 | — | — | US | disclosed |
| US-20080171789-A1 | Catechol protected levodopa diester prodrugs, compositions, and methods of use | XENOPORT, INC. | 2008-07-17 | — | — | US | disclosed |
| WO-2008079387-A1 | CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE | XENOPORT, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171789-A1 | Catechol protected levodopa diester prodrugs, compositions, and methods of use | COMT, PARK7, DDT | MIF 3507/4885LMNA 3425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.